Your browser doesn't support javascript.
loading
Rivaroxaban versus Clopidogrel for Peripheral Artery Disease: A Clinico-Economic Approach of the COMPASS Trial.
Tsilimigras, Diamantis I; Moris, Demetrios; Karaolanis, Georgios; Kakkos, Stavros K; Filis, Konstantinos; Sigala, Fragiska.
Afiliação
  • Tsilimigras DI; First Department of Propaedeutic Surgery, Vascular Unit, National and Kapodistrian University of Athens, Athens, Greece.
  • Moris D; Department of Surgery, Duke University Medical Center, Duke University, Durham, NC, United States.
  • Karaolanis G; First Department of Surgery, Vascular Unit, Laiko University Hospital, Athens, Greece.
  • Kakkos SK; Departments of Vascular Surgery and Nephrology, University Hospital of Patras, Patras, Greece.
  • Filis K; First Department of Propaedeutic Surgery, Vascular Unit, National and Kapodistrian University of Athens, Athens, Greece.
  • Sigala F; First Department of Propaedeutic Surgery, Vascular Unit, National and Kapodistrian University of Athens, Athens, Greece.
Curr Pharm Des ; 24(38): 4516-4517, 2018.
Article em En | MEDLINE | ID: mdl-30621559

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Doenças Cardiovasculares / Doença Arterial Periférica / Rivaroxabana / Clopidogrel / Anticoagulantes Tipo de estudo: Clinical_trials / Health_economic_evaluation Idioma: En Revista: Curr Pharm Des Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Grécia

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Doenças Cardiovasculares / Doença Arterial Periférica / Rivaroxabana / Clopidogrel / Anticoagulantes Tipo de estudo: Clinical_trials / Health_economic_evaluation Idioma: En Revista: Curr Pharm Des Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Grécia